Covid-19 (Temas de Saúde Pública)

Evolução antigênica levará a novas variantes do SARS-CoV-2 com gravidade imprevisível.

22 Mar, 2022 | 11:54h

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity – Nature Reviews Microbiology

 

Comentário no Twitter

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severityhttps://t.co/iFL1AD4q2l@pvmarkov, @ArisKatzourakis & Stilianakis argue that ongoing rapid antigenic evolution is likely to produce new variants that may escape immunity and be more severe. pic.twitter.com/BddNu5DZaq

— Nature Reviews Microbiology (@NatureRevMicro) March 14, 2022

 

---

Efetividade da vacina da Johnson & Johnson em profissionais da área da saúde na África do Sul no período em que as variantes de preocupação beta, e depois a delta, do SARS-CoV-2 eram dominantes.

22 Mar, 2022 | 11:52h

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study – The Lancet

Comentário convidado: Sisonke: reaching several goals together – The Lancet

 

Comentário no Twitter (fio – clique para saber mais)

Single-dose Ad26.COV2.S vaccine in healthcare workers in South Africa shows effectiveness against severe #COVID19 outcomes—and against beta and delta variants, study indicates.https://t.co/S13Ia1H8BT pic.twitter.com/XgbXGcT9XR

— The Lancet (@TheLancet) March 19, 2022

 

---

Relatório do CDC | Efetividade da vacina de mRNA para evitar o uso de ventilação mecânica invasiva e morte associadas à COVID-19 nos EUA.

22 Mar, 2022 | 11:51h

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022 – CDC Morbidity and Mortality Weekly Report

Estudo relacionado: COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 – CDC Morbidity and Mortality Weekly Report

Comentário: Studies show vaccines protect against serious Omicron illness – CIDRAP

 

Comentário no Twitter

New @CDCMMWR study finds #COVID19 vaccines continued to be highly effective at protecting adults from being put on a ventilator or dying during Omicron. All eligible adults should stay up to date w/ COVID-19 vaccines to protect against severe disease. https://t.co/nLi7B2SLJy pic.twitter.com/4o35Vhjg1K

— CDC (@CDCgov) March 18, 2022

 

---

Uso da redução no risco absoluto para orientar a distribuição equitativa das vacinas contra COVID-19.

21 Mar, 2022 | 16:30h

Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines – BMJ Evidence-Based Medicine

Comunicado de imprensa: Researchers find equitable COVID-19 vaccine distribution can target risks in different geographical areas – University of New Mexico

 

Comentário no Twitter

Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines – Analysis by Fassler et al.

What's the role of NNV?#OpenAccess

▶️ https://t.co/Bb3HlJDRXz pic.twitter.com/MPxrGNHxum

— BMJ Evidence-Based Medicine (@BMJ_EBM) March 17, 2022

 

---

Entre profissionais da área da saúde, a efetividade da 4ª dose de vacina contra infecção pela variante Ômicron do SARS-CoV-2 foi de 30% para a Pfizer–BioNTech e 11% para a Moderna.

17 Mar, 2022 | 13:19h

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron – New England Journal of Medicine

Conteúdo relacionado: [Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.

---

Efetividade das vacinas Sputnik V, AstraZeneca e Sinopharm para o risco de infecção e morte por COVID-19 em idosos com mais de 60 anos na Argentina.

17 Mar, 2022 | 13:17h

Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study – The Lancet

Comentário: Evaluating COVID-19 vaccines in the real world – The Lancet

---

COVID-19 e resiliência dos sistemas de saúde em 10 países.

15 Mar, 2022 | 13:23h

COVID-19 and resilience of healthcare systems in ten countries – Nature

---

[Preprint] Alta efetividade da vacina contra Covid-19 grave em idosos na Finlândia antes e depois do surgimento da variante Ômicron.

15 Mar, 2022 | 13:22h

High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron – medRxiv

 

Comentário no Twitter

The acid test for Covid vaccines are protection of the elderly. New data from ~900,000 Finns age 70+ show how 3 shots achieved 96% effectiveness vs hospitalization, before and after Omicron, and even higher vs ICU need https://t.co/TQOQV4SL9a Spikevax=Moderna; Comirnaty=Pfizer pic.twitter.com/mtUCqne1dT

— Eric Topol (@EricTopol) March 14, 2022

 

---

Cuidado a idosos durante a pandemia de COVID-19.

15 Mar, 2022 | 13:18h

Caring for older adults during the COVID-19 pandemic – Clinical Microbiology and Infection

---

“Suprimimos nossa imaginação científica”: 4 especialistas examinam os grandes sucessos e fracassos da resposta à COVID até agora.

15 Mar, 2022 | 13:13h

‘We suppressed our scientific imagination’: four experts examine the big successes and failures of the COVID response so far – The Conversation

---